Global and United States PEGylated Proteins Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.

Market Analysis and Insights: Global and United States PEGylated Proteins Market
This report focuses on global and United States PEGylated Proteins market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global PEGylated Proteins market size is estimated to be worth US$ 3924.4 million in 2022 and is forecast to a readjusted size of US$ 4908.6 million by 2028 with a CAGR of 3.8% during the review period. Fully considering the economic change by this health crisis, by Type, Colony Stimulating Factors accounting for % of the PEGylated Proteins global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Cancer Treatment was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

The major players in global PEGylated Proteins market include UCB, Pfizer, etc. The top 2 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy over 60% of the global market. Colony Stimulating Factors and Interferons are two main types, with a share over 40% altogether. Rheumatoid Arthritis & Crohn's Disease and Cancer Treatment are two key applications, they hold about 60% shares.

Global PEGylated Proteins Scope and Market Size
PEGylated Proteins market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global PEGylated Proteins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the PEGylated Proteins market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the PEGylated Proteins market is segmented into
    Colony Stimulating Factors
    Interferons
    Erythropoietin (EPO)
    Recombinant Factor VIII
    Monoclonal Antibodies
    Others

Segment by Application, the PEGylated Proteins market is segmented into
    Cancer Treatment
    Hepatitis
    Chronic Kidney Disease
    Leukemia
    SCID
    Rheumatoid Arthritis & Crohn's Disease
    Others

Regional and Country-level Analysis
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and PEGylated Proteins Market Share Analysis
PEGylated Proteins market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in PEGylated Proteins business, the date to enter into the PEGylated Proteins market, PEGylated Proteins product introduction, recent developments, etc.

The major vendors covered:
    ENZON Pharmaceuticals
    Merck Sharp & Dohme
    Roche
    Pfizer
    Amgen
    UCB
    Crealta (Savient)

 1 Study Coverage
    1.1 PEGylated Proteins Product Introduction
    1.2 Global PEGylated Proteins Outlook 2017 VS 2022 VS 2028
        1.2.1 Global PEGylated Proteins Sales in US$ Million for the Year 2017-2028
        1.2.2 Global PEGylated Proteins Sales in Volume for the Year 2017-2028
    1.3 United States PEGylated Proteins Outlook 2017 VS 2022 VS 2028
        1.3.1 United States PEGylated Proteins Sales in US$ Million for the Year 2017-2028
        1.3.2 United States PEGylated Proteins Sales in Volume for the Year 2017-2028
    1.4 PEGylated Proteins Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States PEGylated Proteins in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of PEGylated Proteins Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 PEGylated Proteins Market Dynamics
        1.5.1 PEGylated Proteins Industry Trends
        1.5.2 PEGylated Proteins Market Drivers
        1.5.3 PEGylated Proteins Market Challenges
        1.5.4 PEGylated Proteins Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 PEGylated Proteins Market Segment by Type
        2.1.1 Colony Stimulating Factors
        2.1.2 Interferons
        2.1.3 Erythropoietin (EPO)
        2.1.4 Recombinant Factor VIII
        2.1.5 Monoclonal Antibodies
        2.1.6 Others
    2.2 Global PEGylated Proteins Market Size by Type
        2.2.1 Global PEGylated Proteins Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global PEGylated Proteins Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global PEGylated Proteins Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States PEGylated Proteins Market Size by Type
        2.3.1 United States PEGylated Proteins Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States PEGylated Proteins Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States PEGylated Proteins Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 PEGylated Proteins Market Segment by Application
        3.1.1 Cancer Treatment
        3.1.2 Hepatitis
        3.1.3 Chronic Kidney Disease
        3.1.4 Leukemia
        3.1.5 SCID
        3.1.6 Rheumatoid Arthritis & Crohn's Disease
        3.1.7 Others
    3.2 Global PEGylated Proteins Market Size by Application
        3.2.1 Global PEGylated Proteins Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global PEGylated Proteins Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global PEGylated Proteins Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States PEGylated Proteins Market Size by Application
        3.3.1 United States PEGylated Proteins Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States PEGylated Proteins Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States PEGylated Proteins Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global PEGylated Proteins Competitor Landscape by Company
    4.1 Global PEGylated Proteins Market Size by Company
        4.1.1 Top Global PEGylated Proteins Manufacturers Ranked by Revenue (2021)
        4.1.2 Global PEGylated Proteins Revenue by Manufacturer (2017-2022)
        4.1.3 Global PEGylated Proteins Sales by Manufacturer (2017-2022)
        4.1.4 Global PEGylated Proteins Price by Manufacturer (2017-2022)
    4.2 Global PEGylated Proteins Concentration Ratio (CR)
        4.2.1 PEGylated Proteins Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of PEGylated Proteins in 2021
        4.2.3 Global PEGylated Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global PEGylated Proteins Manufacturing Base Distribution, Product Type
        4.3.1 Global PEGylated Proteins Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers PEGylated Proteins Product Type
        4.3.3 Date of International Manufacturers Enter into PEGylated Proteins Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States PEGylated Proteins Market Size by Company
        4.5.1 Top PEGylated Proteins Players in United States, Ranked by Revenue (2021)
        4.5.2 United States PEGylated Proteins Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States PEGylated Proteins Sales by Players (2020, 2021 & 2022)

 5 Global PEGylated Proteins Market Size by Region
    5.1 Global PEGylated Proteins Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global PEGylated Proteins Market Size in Volume by Region (2017-2028)
        5.2.1 Global PEGylated Proteins Sales in Volume by Region: 2017-2022
        5.2.2 Global PEGylated Proteins Sales in Volume Forecast by Region (2023-2028)
    5.3 Global PEGylated Proteins Market Size in Value by Region (2017-2028)
        5.3.1 Global PEGylated Proteins Sales in Value by Region: 2017-2022
        5.3.2 Global PEGylated Proteins Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America PEGylated Proteins Market Size YoY Growth 2017-2028
        6.1.2 North America PEGylated Proteins Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific PEGylated Proteins Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific PEGylated Proteins Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe PEGylated Proteins Market Size YoY Growth 2017-2028
        6.3.2 Europe PEGylated Proteins Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America PEGylated Proteins Market Size YoY Growth 2017-2028
        6.4.2 Latin America PEGylated Proteins Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa PEGylated Proteins Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa PEGylated Proteins Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 ENZON Pharmaceuticals
        7.1.1 ENZON Pharmaceuticals Corporation Information
        7.1.2 ENZON Pharmaceuticals Description and Business Overview
        7.1.3 ENZON Pharmaceuticals PEGylated Proteins Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 ENZON Pharmaceuticals PEGylated Proteins Products Offered
        7.1.5 ENZON Pharmaceuticals Recent Development
    7.2 Merck Sharp & Dohme
        7.2.1 Merck Sharp & Dohme Corporation Information
        7.2.2 Merck Sharp & Dohme Description and Business Overview
        7.2.3 Merck Sharp & Dohme PEGylated Proteins Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Merck Sharp & Dohme PEGylated Proteins Products Offered
        7.2.5 Merck Sharp & Dohme Recent Development
    7.3 Roche
        7.3.1 Roche Corporation Information
        7.3.2 Roche Description and Business Overview
        7.3.3 Roche PEGylated Proteins Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Roche PEGylated Proteins Products Offered
        7.3.5 Roche Recent Development
    7.4 Pfizer
        7.4.1 Pfizer Corporation Information
        7.4.2 Pfizer Description and Business Overview
        7.4.3 Pfizer PEGylated Proteins Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Pfizer PEGylated Proteins Products Offered
        7.4.5 Pfizer Recent Development
    7.5 Amgen
        7.5.1 Amgen Corporation Information
        7.5.2 Amgen Description and Business Overview
        7.5.3 Amgen PEGylated Proteins Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Amgen PEGylated Proteins Products Offered
        7.5.5 Amgen Recent Development
    7.6 UCB
        7.6.1 UCB Corporation Information
        7.6.2 UCB Description and Business Overview
        7.6.3 UCB PEGylated Proteins Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 UCB PEGylated Proteins Products Offered
        7.6.5 UCB Recent Development
    7.7 Crealta (Savient)
        7.7.1 Crealta (Savient) Corporation Information
        7.7.2 Crealta (Savient) Description and Business Overview
        7.7.3 Crealta (Savient) PEGylated Proteins Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Crealta (Savient) PEGylated Proteins Products Offered
        7.7.5 Crealta (Savient) Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 PEGylated Proteins Industry Chain Analysis
    8.2 PEGylated Proteins Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 PEGylated Proteins Distributors
    8.3 PEGylated Proteins Production Mode & Process
    8.4 PEGylated Proteins Sales and Marketing
        8.4.1 PEGylated Proteins Sales Channels
        8.4.2 PEGylated Proteins Distributors
    8.5 PEGylated Proteins Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. PEGylated Proteins CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. PEGylated Proteins Market Trends
    Table 3. PEGylated Proteins Market Drivers
    Table 4. PEGylated Proteins Market Challenges
    Table 5. PEGylated Proteins Market Restraints
    Table 6. Global PEGylated Proteins Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States PEGylated Proteins Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global PEGylated Proteins Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States PEGylated Proteins Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top PEGylated Proteins Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global PEGylated Proteins Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global PEGylated Proteins Revenue Share by Manufacturer, 2017-2022
    Table 13. Global PEGylated Proteins Sales by Manufacturer, (g), 2017-2022
    Table 14. Global PEGylated Proteins Sales Share by Manufacturer, 2017-2022
    Table 15. Global PEGylated Proteins Price by Manufacturer (2017-2022) & (US$/mg)
    Table 16. Global PEGylated Proteins Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global PEGylated Proteins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEGylated Proteins as of 2021)
    Table 18. Top Players of PEGylated Proteins in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers PEGylated Proteins Product Type
    Table 20. Date of International Manufacturers Enter into PEGylated Proteins Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top PEGylated Proteins Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States PEGylated Proteins Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States PEGylated Proteins Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States PEGylated Proteins Sales by Players, (g), 2020, 2021 & 2022
    Table 26. United States PEGylated Proteins Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global PEGylated Proteins Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global PEGylated Proteins Sales in Volume by Region (2017-2022) & (g)
    Table 29. Global PEGylated Proteins Sales in Volume Forecast by Region (2023-2028) & (g)
    Table 30. Global PEGylated Proteins Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global PEGylated Proteins Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America PEGylated Proteins Sales in Volume by Country (2017-2028) & (g)
    Table 33. North America PEGylated Proteins Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific PEGylated Proteins Sales in Volume by Region (2017-2028) & (g)
    Table 35. Asia Pacific PEGylated Proteins Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe PEGylated Proteins Sales in Volume by Country (2017-2028) & (g)
    Table 37. Europe PEGylated Proteins Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America PEGylated Proteins Sales in Volume by Country (2017-2028) & (g)
    Table 39. Latin Americaa PEGylated Proteins Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa PEGylated Proteins Sales in Volume by Country (2017-2028) & (g)
    Table 41. Middle East and Africa PEGylated Proteins Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. ENZON Pharmaceuticals Corporation Information
    Table 43. ENZON Pharmaceuticals Description and Business Overview
    Table 44. ENZON Pharmaceuticals PEGylated Proteins Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
    Table 45. ENZON Pharmaceuticals PEGylated Proteins Product
    Table 46. ENZON Pharmaceuticals Recent Development
    Table 47. Merck Sharp & Dohme Corporation Information
    Table 48. Merck Sharp & Dohme Description and Business Overview
    Table 49. Merck Sharp & Dohme PEGylated Proteins Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
    Table 50. Merck Sharp & Dohme Product
    Table 51. Merck Sharp & Dohme Recent Development
    Table 52. Roche Corporation Information
    Table 53. Roche Description and Business Overview
    Table 54. Roche PEGylated Proteins Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
    Table 55. Roche Product
    Table 56. Roche Recent Development
    Table 57. Pfizer Corporation Information
    Table 58. Pfizer Description and Business Overview
    Table 59. Pfizer PEGylated Proteins Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
    Table 60. Pfizer Product
    Table 61. Pfizer Recent Development
    Table 62. Amgen Corporation Information
    Table 63. Amgen Description and Business Overview
    Table 64. Amgen PEGylated Proteins Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
    Table 65. Amgen Product
    Table 66. Amgen Recent Development
    Table 67. UCB Corporation Information
    Table 68. UCB Description and Business Overview
    Table 69. UCB PEGylated Proteins Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
    Table 70. UCB Product
    Table 71. UCB Recent Development
    Table 72. Crealta (Savient) Corporation Information
    Table 73. Crealta (Savient) Description and Business Overview
    Table 74. Crealta (Savient) PEGylated Proteins Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2017-2022)
    Table 75. Crealta (Savient) Product
    Table 76. Crealta (Savient) Recent Development
    Table 77. Key Raw Materials Lists
    Table 78. Raw Materials Key Suppliers Lists
    Table 79. PEGylated Proteins Customers List
    Table 80. PEGylated Proteins Distributors List
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. PEGylated Proteins Product Picture
    Figure 2. Global PEGylated Proteins Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global PEGylated Proteins Market Size 2017-2028 (US$ Million)
    Figure 4. Global PEGylated Proteins Sales 2017-2028 (g)
    Figure 5. United States PEGylated Proteins Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States PEGylated Proteins Market Size 2017-2028 (US$ Million)
    Figure 7. United States PEGylated Proteins Sales 2017-2028 (g)
    Figure 8. United States PEGylated Proteins Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States PEGylated Proteins Market Share in Global, in Volume (g) 2017-2028
    Figure 10. PEGylated Proteins Report Years Considered
    Figure 11. Product Picture of Colony Stimulating Factors
    Figure 12. Product Picture of Interferons
    Figure 13. Product Picture of Erythropoietin (EPO)
    Figure 14. Product Picture of Recombinant Factor VIII
    Figure 15. Product Picture of Monoclonal Antibodies
    Figure 16. Product Picture of Others
    Figure 17. Global PEGylated Proteins Market Share by Type in 2022 & 2028
    Figure 18. Global PEGylated Proteins Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 19. Global PEGylated Proteins Sales Market Share in Value by Type (2017-2028)
    Figure 20. Global PEGylated Proteins Sales by Type (2017-2028) & (g)
    Figure 21. Global PEGylated Proteins Sales Market Share in Volume by Type (2017-2028)
    Figure 22. Global PEGylated Proteins Price by Type (2017-2028) & (US$/mg)
    Figure 23. United States PEGylated Proteins Market Share by Type in 2022 & 2028
    Figure 24. United States PEGylated Proteins Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 25. United States PEGylated Proteins Sales Market Share in Value by Type (2017-2028)
    Figure 26. United States PEGylated Proteins Sales by Type (2017-2028) & (g)
    Figure 27. United States PEGylated Proteins Sales Market Share in Volume by Type (2017-2028)
    Figure 28. United States PEGylated Proteins Price by Type (2017-2028) & (US$/mg)
    Figure 29. Product Picture of Cancer Treatment
    Figure 30. Product Picture of Hepatitis
    Figure 31. Product Picture of Chronic Kidney Disease
    Figure 32. Product Picture of Leukemia
    Figure 33. Product Picture of SCID
    Figure 34. Product Picture of Rheumatoid Arthritis & Crohn's Disease
    Figure 35. Product Picture of Others
    Figure 36. Global PEGylated Proteins Market Share by Application in 2022 & 2028
    Figure 37. Global PEGylated Proteins Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. Global PEGylated Proteins Sales Market Share in Value by Application (2017-2028)
    Figure 39. Global PEGylated Proteins Sales by Application (2017-2028) & (g)
    Figure 40. Global PEGylated Proteins Sales Market Share in Volume by Application (2017-2028)
    Figure 41. Global PEGylated Proteins Price by Application (2017-2028) & (US$/mg)
    Figure 42. United States PEGylated Proteins Market Share by Application in 2022 & 2028
    Figure 43. United States PEGylated Proteins Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 44. United States PEGylated Proteins Sales Market Share in Value by Application (2017-2028)
    Figure 45. United States PEGylated Proteins Sales by Application (2017-2028) & (g)
    Figure 46. United States PEGylated Proteins Sales Market Share in Volume by Application (2017-2028)
    Figure 47. United States PEGylated Proteins Price by Application (2017-2028) & (US$/mg)
    Figure 48. North America PEGylated Proteins Sales in Volume Growth Rate 2017-2028 (g)
    Figure 49. North America PEGylated Proteins Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 50. U.S. PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Canada PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Europe PEGylated Proteins Sales in Volume Growth Rate 2017-2028 (g)
    Figure 53. Europe PEGylated Proteins Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. Germany PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. France PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.K. PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Italy PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Russia PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Asia-Pacific PEGylated Proteins Sales in Volume Growth Rate 2017-2028 (g)
    Figure 60. Asia-Pacific PEGylated Proteins Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 61. China PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Japan PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. South Korea PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. India PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Australia PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. China Taiwan PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Indonesia PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Thailand PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Malaysia PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Latin America PEGylated Proteins Sales in Volume Growth Rate 2017-2028 (g)
    Figure 71. Latin America PEGylated Proteins Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Mexico PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Brazil PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Argentina PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Middle East & Africa PEGylated Proteins Sales in Volume Growth Rate 2017-2028 (g)
    Figure 76. Middle East & Africa PEGylated Proteins Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 77. Turkey PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Saudi Arabia PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 79. UAE PEGylated Proteins Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 80. PEGylated Proteins Value Chain
    Figure 81. PEGylated Proteins Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed

PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.

Market Analysis and Insights: Global and United States PEGylated Proteins Market
This report focuses on global and United States PEGylated Proteins market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global PEGylated Proteins market size is estimated to be worth US$ 3924.4 million in 2022 and is forecast to a readjusted size of US$ 4908.6 million by 2028 with a CAGR of 3.8% during the review period. Fully considering the economic change by this health crisis, by Type, Colony Stimulating Factors accounting for % of the PEGylated Proteins global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Cancer Treatment was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

The major players in global PEGylated Proteins market include UCB, Pfizer, etc. The top 2 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy over 60% of the global market. Colony Stimulating Factors and Interferons are two main types, with a share over 40% altogether. Rheumatoid Arthritis & Crohn's Disease and Cancer Treatment are two key applications, they hold about 60% shares.

Global PEGylated Proteins Scope and Market Size
PEGylated Proteins market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global PEGylated Proteins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the PEGylated Proteins market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the PEGylated Proteins market is segmented into
    Colony Stimulating Factors
    Interferons
    Erythropoietin (EPO)
    Recombinant Factor VIII
    Monoclonal Antibodies
    Others

Segment by Application, the PEGylated Proteins market is segmented into
    Cancer Treatment
    Hepatitis
    Chronic Kidney Disease
    Leukemia
    SCID
    Rheumatoid Arthritis & Crohn's Disease
    Others

Regional and Country-level Analysis
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and PEGylated Proteins Market Share Analysis
PEGylated Proteins market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in PEGylated Proteins business, the date to enter into the PEGylated Proteins market, PEGylated Proteins product introduction, recent developments, etc.

The major vendors covered:
    ENZON Pharmaceuticals
    Merck Sharp & Dohme
    Roche
    Pfizer
    Amgen
    UCB
    Crealta (Savient)